Ustekinumab improves health-related quality of life in Chinese patients with moderate-to-severe plaque psoriasis: Results from the LOTUS trial and curative effect observation.

Authors
Category Primary study
JournalJournal of Clinical Dermatology
Year 2014
This article has no abstract
Epistemonikos ID: 1377fa1ae26bbe1020c7d5d2dd6e5a4770c04ba6
First added on: Feb 15, 2018